Synergistic Anti-Cancer Effects of AKT and SRC Inhibition in Human Pancreatic Cancer Cells

Kang Ahn1, Young Moon O1, Young Geon Ji2

  • 1Department of Physiology, School of Medicine, CHA University, Seongnam, Korea.

Abstract

Insights

Combined inhibition of protein kinase B (AKT) and SRC effectively suppresses pancreatic cancer growth and metastasis. This dual targeting strategy shows synergistic efficacy in preclinical models, offering a promising therapeutic approach for pancreatic cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic cancer is an aggressive malignancy with limited treatment options.
  • Protein kinase B (AKT) and SRC are key signaling pathways implicated in cancer cell proliferation and metastasis.

Purpose of the Study:

  • To evaluate the combined inhibitory effects of AKT and SRC on human pancreatic cancer growth and metastatic potential.
  • To explore the underlying molecular mechanisms of this combined inhibition.

Main Methods:

  • Utilized specific inhibitors (10-DEBC for AKT, PP2 for SRC) and small interfering RNA (siRNA) for gene knockdown.
  • Assessed cell proliferation, migration, invasion, and Western blot analysis of key signaling proteins.
  • Employed a human pancreatic cancer xenotransplant model to evaluate in vivo efficacy.

Main Results:

  • Simultaneous inhibition of AKT and SRC significantly suppressed pancreatic cancer cell proliferation and tumor growth in vivo.
  • Combined treatment markedly reduced cancer cell migration and invasion, indicating decreased metastatic potential.
  • The dual inhibition downregulated the phosphorylation of mTOR and ERK signaling pathways.

Conclusions:

  • Combined targeting of AKT and SRC demonstrates synergistic efficacy against pancreatic cancer growth and metastasis.
  • This strategy presents a promising therapeutic avenue for managing pancreatic cancer progression.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K